| |
|
|
|
|
|
|
|||
|
Blood, 15 January 2008, Vol. 111, No. 2, pp. 723-731. Prepublished online as a Blood First Edition Paper on October 1, 2007; DOI 10.1182/blood-2007-05-091173.
IMMUNOBIOLOGY Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells1 Department of Molecular and Cellular Biology and Pathology, Federico II University of Naples, Naples, Italy; 2 Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC; 3 Laboratory of Immunobiology of Cardiovascular Diseases, Department of Medical Science and Rehabilitation, and 4 Laboratory of Cellular and Molecular Pathology, Scientific Institute for Research, Hospitalization, and Health Care (IRCCS) San Raffaele Pisana, Rome, Italy; 5 Center for Genetic Engineering (CEINGE) Advanced Biotechnology, Naples, Italy; 6 Department of Biochemistry and Medical Biotechnology, Federico II University of Naples, Naples, Italy; 7 Institute of Physics, University Sacro Cuore, Rome, Italy; 8 Department of Endocrinology and Molecular and Clinical Oncology 9 Department of Biomorphological and Functional Science, and 10 Interdepartimental Center for Immunological Science, Federico II University of Naples, Naples, Italy Microbial products, including lipopolysaccharide (LPS), an agonist of Toll-like receptor 4 (TLR4), regulate the lifespan of dendritic cells (DCs) by largely undefined mechanisms. Here, we identify a role for calcium-calmodulin–dependent kinase IV (CaMKIV) in this survival program. The pharmacologic inhibition of CaMKs as well as ectopic expression of kinase-inactive CaMKIV decrease the viability of monocyte-derived DCs exposed to bacterial LPS. The defect in TLR4 signaling includes a failure to accumulate the phosphorylated form of the cAMP response element-binding protein (pCREB), Bcl-2, and Bcl-xL. CaMKIV null mice have a decreased number of DCs in lymphoid tissues and fail to accumulate mature DCs in spleen on in vivo exposure to LPS. Although isolated Camk4–/– DCs are able to acquire the phenotype typical of mature cells and release normal amounts of cytokines in response to LPS, they fail to accumulate pCREB, Bcl-2, and Bcl-xL and therefore do not survive. The transgenic expression of Bcl-2 in CaMKIV null mice results in full recovery of DC survival in response to LPS. These results reveal a novel link between TLR4 and a calcium-dependent signaling cascade comprising CaMKIV-CREB-Bcl-2 that is essential for DC survival.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||